Capital expenditure decreased 65.3%
Capital expenditure changed -65.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -65.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +52.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +112.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +133.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +31.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed +3708 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed +1803 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +48.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +69.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +1726 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -49.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +152.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed +30.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +30.1% from the comparable as-filed period.
Total assets changed -14.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +237.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed -502 basis points from the comparable as-filed period.
Debt / revenue changed -1213 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -15.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -397 basis points from the comparable as-filed period.
Gross debt changed +19.8% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Reported total debt changed +19.8% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Shares outstanding changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Inventory changed +17.0% from the comparable as-filed period.
Debt / assets changed +184 basis points from the comparable as-filed period.
Receivables / revenue changed +64 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.